| 2010/09/01 |
 |
Dissolution of a Subsidiary |
| 2010/08/02 |
|
Financial Results for the First Quarter of Fiscal Year 2010 |
| 2010/07/23 |
|
Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference |
| 2010/07/21 |
|
Shionogi-ViiV Healthcare Announces Commitment to Phase III Development Programme for Investigational Once-Daily HIV Integrase Inhibitor |
| 2010/07/01 |
|
Shionogi announces reorganization of US Operations, new leadership. |
| 2010/06/30 |
|
CRESTOR® PATENT UPHELD BY US DISTRICT COURT, DISTRICT OF DELAWARE |
| 2010/06/17 |
|
Establishment of an Organization |
| 2010/06/01 |
|
Shionogi Announces the Conducting of Drug Discovery Competition FINDS2010 -Drug seeds fostering type- |
| 2010/05/10 |
|
Shionogi Establishes Shionogi Techno Advance Research Co., Ltd. |
| 2010/05/10 |
|
New Quinolone Oral Antibiotic Avelox®: Sales Rights Transfer |
| 2010/04/27 |
|
Shionogi Appeals Patent Infringement lawsuit for Flomox® (Oral cephem antibiotic agent) to the Intellectual Property High Court |
| 2010/04/16 |
|
Launch of an Antidepressant Drug,"Cymbalta® Capsules 20mg and 30mg" |
| 2010/03/16 |
|
SHIONOGI'S THIRD MEDIUM-TERM BUSINESS PLAN |
| 2010/03/11 |
|
Shionogi and TAKATA SEIYAKU Announce Agreement on Succession of Marketing and Manufacturing Rights |
| 2010/03/02 |
|
SHIONOGI ENTERS INTO EXCLUSIVE LICENSE AGREEMENT WITH QUATRX PHARMACEUTICALS TO MARKET OSPEMIFENE |
| 2010/02/22 |
|
NOTIFICATION OF SUBSIDIARY TRANSFER |
| 2010/02/22 |
|
Shionogi Announces Appointment of Directors, Corporate Officers and Corporate Reorganization |
| 2010/02/15 |
|
Shionogi Files an Additional Application for Pediatric Use of "RAPIACTA®" a Novel Anti-viral Drug for Influenza |
| 2010/02/01 |
|
Financial Results for the Third Quarter of Fiscal Year 2009 |
| 2010/01/26 |
|
A Novel Anti-viral Drug for Influenza,"RAPIACTA 300mg Bag for Intravenous Drip Infusion" and "RAPIACTA 150mg Vial for Intravenous Drip Infusion" Launch |
| 2010/01/25 |
|
Shionogi Supports Relief Efforts for Haiti Earthquake Victims |
| 2010/01/20 |
|
Shionogi Receives Marketing and Manufacturing Approval of an Antidepressant Drug,"Cymbalta ®Capsules 20mg and 30mg" |
| 2010/01/13 |
|
Shionogi Receives Marketing and Manufacturing Approval of a Novel Anti-viral Drug for Influenza, "RAPIACTA 300mg Bag for Intravenous Drip Infusion" and "RAPIACTA 150mg Vial for Intravenous Drip Infusion" |
| 2010/01/12 |
|
SCIELE PHARMA, INC., A SHIONOGI GROUP COMPANY, ANNOUNCES NAME CHANGE |
